Pharmacokinetics of butorphanol and evaluation of physiologic and behavioral effects after intravenous and intramuscular administration to neonatal foals

Journal of Veterinary Internal Medicine

Volumn 22, Issue 6, 2008, Pages 1417-1426

  Arguedas, M G ^a   Hines, M T ^a   Papich, M G ^b   Farnsworth, K D ^a   Sellon, Debra C ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

Drug disposition; Feeding; Narcotic agonist antagonist; Pedometer; Sedation

Indexed keywords

BUTORPHANOL; NARCOTIC ANALGESIC AGENT;

ANIMAL; ANIMAL BEHAVIOR; ARTICLE; DRUG EFFECT; FEMALE; HORSE; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEWBORN; TIME;

ANALGESICS, OPIOID; ANIMALS; ANIMALS, NEWBORN; BEHAVIOR, ANIMAL; BUTORPHANOL; FEMALE; HORSES; INJECTIONS, INTRAMUSCULAR; INJECTIONS, INTRAVENOUS; MALE; TIME FACTORS;

ANIMALIA; EQUIDAE;

EID: 57149092156     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2008.0200.x     Document Type: Article

References (50)

1. Carbajal R, Gall O, Annequin D. Pain management in neonates. Expert Rev Neurother 2004;4:491-505.
2. Coleman MM, Solarin K, Smith C. Assessment and management of pain and distress in the neonate. Adv Neonatal Care 2002;2:123-136; quiz 137-129.
3. Sellon DC, Roberts MC, Blikslager AT, et al. Effects of continuous rate intravenous infusion of butorphanol on physiologic and outcome variables in horses after celiotomy. J Vet Intern Med 2004;18:555-563.
4. Geor RJ, Petrie L, Papich MG, et al. The protective effects of sucralfate and ranitidine in foals experimentally intoxicated with phenylbutazone. Can J Vet Res 1989;53:231-238.
5. Naylor JM, Garven E, Fraser L. A comparison of romifidine and xylazine in foals: The effects on sedation and analgesia. Equine Vet Educ 1997;9:329-334.
6. Oijala M, Katila T. Detomidine (Domosedan) in foals: Sedative and analgesic effects. Equine Vet J 1988;20:327-330.
7. Tibboel D, Anand KJ, van den Anker JN. The pharmacological treatment of neonatal pain. Semin Fetal Neonatal Med 2005;10:195-205.
8. Kalpravidh M, Lumb WV, Wright M, et al. Analgesic effects of butorphanol in horses: Dose-response studies. Am J Vet Res 1984;45:211-216.
9. Muir WW, Robertson JT. Visceral analgesia: Effects of xylazine, butorphanol, meperidine, and pentazocine in horses. Am J Vet Res 1985;46:2081-2084.
10. Skarda RT, Muir WW III. Comparison of electroacupuncture and butorphanol on respiratory and cardiovascular effects and rectal pain threshold after controlled rectal distention in mares. Am J Vet Res 2003;64:137-144.
11. Robertson JT, Muir WW, Sams R. Cardiopulmonary effects of butorphanol tartrate in horses. Am J Vet Res 1981;42:41-44.
12. Sellon DC, Monroe VL, Roberts MC, et al. Pharmacokinetics and adverse effects of butorphanol administered by single intravenous injection or continuous intravenous infusion in horses. Am J Vet Res 2001;62:183-189.
13. Gabrielsson J, Weiner D. Pharmacokinetic and pharmacodynamic data analysis: Concepts and applications, 3rd ed. Stockholm: Swedish Pharmaceutical Press; 2001
14. Gibaldi M, Perrier P. Pharmacokinetics, 2nd ed. New York: Marcel Dekker Inc; 1982:473.
15. Bouwmeester NJ, van den Anker JN, Hop WC, et al. Age- and therapy-related effects on morphine requirements and plasma concentrations of morphine and its metabolites in postoperative infants. Br J Anaesth 2003;90:642-652.
16. Bouwmeester NJ, Hop WC, van Dijk M, et al. Postoperative pain in the neonate: Age-related differences in morphine requirements and metabolism. Intensive Care Med 2003;29:2009-2015.
17. Sellon DC, Papich MG, Palmer L. Pharmacokinetics of butorphanol in horses after intramuscular injection. 2008, in press.
18. Toutain PL, Bousquet-Melou A. Volumes of distribution. J Vet Pharmacol Ther 2004;27:441-453.
19. Baggot JD, Short CR. Drug disposition in the neonatal animal, with particular reference to the foal. Equine Vet J 1984;16:364-367.
20. Adamson PJ, Wilson WD, Baggot JD, et al. Influence of age on the disposition kinetics of chloramphenicol in equine neonates. Am J Vet Res 1991;52:426-431.
21. Bucki EP, Giguere S, Macpherson M, et al. Pharmacokinetics of once-daily amikacin in healthy foals and therapeutic drug monitoring in hospitalized equine neonates. J Vet Intern Med 2004;18:728-733.
22. Crisman MV, Wilcke JR, Sams RA. Pharmacokinetics of flunixin meglumine in healthy foals less than twenty-four hours old. Am J Vet Res 1996;57:1759-1761.
23. Norman WM, Court MH, Greenblatt DJ. Age-related changes in the pharmacokinetic disposition of diazepam in foals. Am J Vet Res 1997;58:878-880.
24. Wilcke JR, Crisman MV, Scarratt WK, et al. Pharmacokinetics of ketoprofen in healthy foals less than twenty-four hours old. Am J Vet Res 1998;59:290-292.
25. Boxenbaum H, Ronfeld R. Interspecies pharmacokinetic scaling and the Dedrick plots. Am J Physiol 1983;245:R768-R775.
26. Kearns GL, Abdel-Rahman SM, Alander SW, et al. Developmental pharmacology - Drug disposition, action, and therapy in infants and children. N Engl J Med 2003;349:1157-1167.
27. Toutain PL, Bousquet-Melou A. Plasma terminal half-life. J Vet Pharmacol Ther 2004;27:427-439.
28. Kalpravidh M, Lumb WV, Wright M, et al. Effects of butorphanol, flunixin, levorphanol, morphine, and xylazine in ponies. Am J Vet Res 1984;45:217-223.
29. Kamerling S, Weckman T, Donahoe J, et al. Dose related effects of the kappa agonist U-50, 488H on behaviour, nociception and autonomic response in the horse. Equine Vet J 1988;20:114-118.
30. Orsini J. Butorphanol tartrate: Pharmacology and clinical indications. Compend Contin Educ Pract Vet 1988;10:849-854.
31. Boscan P, Van Hoogmoed LM, Farver TB, et al. Evaluation of the effects of the opioid agonist morphine on gastrointestinal tract function in horses. Am J Vet Res 2006;67:992-997.
32. Senior JM, Pinchbeck GL, Dugdale AH, et al. Retrospective study of the risk factors and prevalence of colic in horses after orthopaedic surgery. Vet Rec 2004;155:321-325.
33. Merritt AM, Campbell-Thompson ML, Lowrey S. Effect of butorphanol on equine antroduodenal motility. Equine Vet J 1989 (Suppl):21-23.
34. Roger T, Bardon T, Ruckebusch Y. Comparative effects of mu and kappa opiate agonists on the cecocolic motility in the pony. Can J Vet Res 1994;58:163-166.
35. Nolan AM, Besley W, Reid J, et al. The effects of butorphanol on locomotor activity in ponies: A preliminary study. J Vet Pharmacol Ther 1994;17:323-326.
36. Spadavecchia C, Arendt-Nielsen L, Spadavecchia L, et al. Effects of butorphanol on the withdrawal reflex using threshold, suprathreshold and repeated subthreshold electrical stimuli in conscious horses. Vet Anaesth Analg 2007;34:48-58.
37. Gingerich DA, Rourke JE, Chatfield RC. Butorphanol tartrate: A new analgesic to relieve the pain of equine colic. Vet Med 1985;80:72-77.
38. Jochle W, Moore JN, Brown J, et al. Comparison of detomidine, butorphanol, flunixin meglumine and xylazine in clinical cases of equine colic. Equine Vet J 1989 (Suppl):111-116.
39. Jackson HC, Kitchen I. Behavioural effects of selective mu-, kappa-, and delta-opioid agonists in neonatal rats. Psychopharmacology (Berlin) 1989;97:404-409.
40. McLaughlin CR, Tao Q, Abood ME. Analysis of the antinociceptive actions of the kappa-opioid agonist enadoline (CI-977) in neonatal and adult rats: Comparison to kappa-opioid receptor mRNA ontogeny. Drug Alcohol Depend 1995;38:261-269.
41. Kitchen I, Kelly M, Viveros MP. Ontogenesis of kappa-opioid receptors in rat brain using [3 H]U-69593 as a binding ligand. Eur J Pharmacol 1990;175:93-96.
42. Spain JW, Roth BL, Coscia CJ. Differential ontogeny of multiple opioid receptors (mu, delta, and kappa). J Neurosci 1985;5:584-588.
43. Chan CB, Spierenburg M, Ihle SL, et al. Use of pedometers to measure physical activity in dogs. J Am Vet Med Assoc 2005;226:2010-2015.
44. Holland JL, Kronfeld DS, Meacham TN. Behavior of horses is affected by soy lecithin and corn oil in the diet. J Anim Sci 1996;74:1252-1255.
45. Powell TL. Pedometer measurements of the distance walked by grazing sheep in relation to weather. J Br Grassl Soc 1968;23:98-102.
46. Combie J, Dougherty J, Nugent E. Dose and time response relationship for behavioral responses to morphine, meperidine, pentazocine, anileridine, methadone, and hydromorphone. J Equine Med Surg 1979;3:377-385.
47. Bodnar RJ. Recent advances in the understanding of the effects of opioid agents on feeding and appetite. Expert Opin Investig Drugs 1998;7:485-497.
48. Kim EM, Shi Q, Olszewski PK, et al. Identification of central sites involved in butorphanol-induced feeding in rats. Brain Res 2001;907:125-129.
49. Levine AS, Morley JE. Butorphanol tartrate induces feeding in rats. Life Sci 1983;32:781-785.
50. Morley JE, Levine AS, Gosnell BA, et al. Which opioid receptor mechanism modulates feeding? Appetite 1984;5:61-68.